CHS Inc.
NASDAQ:CHSCLAgricultural Farm Products
-$0.05 today
- Market cap
- $294.90M
- Beta
- 0.10
- P/E (TTM)
- 0.0
- EPS (TTM)
- $0.00
- Dividend yield
- 7.37%
Volume 0.12M
Average 0.02M
CHSCL Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
CHS Inc.NASDAQ: CHSCL
Free Cash Flow · Q2 FY2026 · quarter ended Feb 2026
Free cash flow dips below year-ago levels
Q2 FY2026 free cash flow of $449.03M (cash outflow) fell 56.7% year over year, behind the +355.2% change in trailing-twelve-month free cash flow. Sequentially, it fell 1.9% from the prior quarter.
Context
- Free cash flow amounted to 1.0% of revenue in FY2025, unchanged from a year earlier.
- Free cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -56.7% toward the trailing-twelve-month pace of +355.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (364.17M) USD
- Year-over-year change
- -182.5%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | (364.17M) | -182.5% |
| FY2024 | 2024-08-31 | 441.37M | -82.4% |
| FY2023 | 2023-08-31 | 2.5B | +59.7% |
| FY2022 | 2022-08-31 | 1.57B | +292.7% |
| FY2021 | 2021-08-31 | 399.1M | — |
Free Cash Flow vs competitors
How CHSCL compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +355.2% is the 3rd highest of 10, against a peer median of +32.8%.
- Free cash flow amounts to 2.4% of revenue for CHSCL, versus a peer median of 7.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $868.36M USD | +355.2% | — | 2.4% | |
| LTM Mar 2026 | ₪47.39M ILS | +442.9% | +216.6% | 7.7% | |
| LTM Apr 2026 | $47.11M USD | -60.3% | — | 2.6% | |
| LTM Mar 2026 | R$46.82M BRL | +256.1% | -27.3% | 8.6% | |
| LTM Apr 2026 | $32.99M USD | -320.1% | — | 24.9% | |
AFRIForafric Global PLC | LTM Jun 2024 | $30.01M USD | — | -86.3% | 9.2% |
| LTM Mar 2026 | $23.02M USD | +32.8% | — | 4.7% | |
| LTM Mar 2026 | $14.49M USD | +446.1% | — | 6.4% | |
| LTM Mar 2026 | $12.66M USD | +160.9% | — | 77.1% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $3.46M USD | -41.1% | +33.8% | 5.7% |
| LTM Mar 2026 | $2.02M USD | -58.5% | -54.9% | 0.5% | |
| Peer median (excluding CHSCL) | — | +32.8% | -27.3% | 7.0% | |
Competitors are the stored peer set for CHSCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Net Income | 553.95M | 1.68B | 1.9B | 1.1B | 598M |
| Depreciation & Amortization | 461.73M | 461.97M | 464.62M | 481.72M | 651.43M |
| Deferred Income Tax | (11.96M) | 39.55M | (6.43M) | (109.85M) | (38.74M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (190.45M) | (247.58M) | 992.11M | (324.36M) | (464.4M) |
| Accounts Receivables | (568.75M) | (547.56M) | 645.78M | (335.97M) | 7M |
| Inventory | (549.22M) | (317.92M) | 437.69M | 147.76M | (53.18M) |
| Accounts Payables | 1.01B | 555.45M | (127.4M) | (213.79M) | (276.11M) |
| Other Working Capital | (79.7M) | 62.46M | 36.03M | 77.64M | (142.1M) |
| Other Non-Cash Items | (55.47M) | 13.82M | (66.55M) | 123.04M | (110.49M) |
| Operating Cash Flow | 757.81M | 1.95B | 3.28B | 1.27B | 635.79M |
| Capital Expenditures | (358.72M) | (379.21M) | (781.94M) | (831.51M) | (999.96M) |
| Acquisitions (Net) | 102.11M | 87.47M | 29.71M | 15.82M | (237.17M) |
| Purchases of Investments | 0 | 0 | 0 | (500.18M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 513.31M |
| Other Investing Activities | 154.94M | (165.34M) | (197.97M) | (947.23M) | (1.16B) |
| Investing Cash Flow | (101.67M) | (457.08M) | (950.19M) | (1.43B) | (880.6M) |
| Debt Repayment | (41.84M) | (785.17M) | (202.42M) | 74.22M | 525.54M |
| Common Stock Issued | 79.38M | 111.82M | 0 | 0 | 0 |
| Common Stock Repurchased | (79.38M) | (111.82M) | (495.79M) | (355.93M) | (287.68M) |
| Dividends Paid | (168.67M) | (168.67M) | (168.67M) | (168.67M) | (469.03M) |
| Other Financing Activities | (36.7M) | (48.03M) | (528.59M) | (363.88M) | 600K |
| Financing Cash Flow | (326.59M) | (1.11B) | (1.4B) | (814.25M) | (230.57M) |
| Effect of Forex Changes | (4.06M) | (14.76M) | 2.59M | 2.24M | 773K |
| Net Change in Cash | 325.49M | 360.99M | 941.11M | (970.73M) | (474.6M) |
| Free Cash Flow | 399.1M | 1.57B | 2.5B | 441.37M | (364.17M) |
CHS Inc.
NASDAQ:CHSCL
Intrinsic Alpha fair value
Locked
Current Price
$24.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.